Abstract:Elaborate regulation of innate immunity is necessary for the host to effectively respond to invading pathogens. As an important component of antiviral immunity transcription factors, the stability and activity of interferon (IFN) regulatory factor 3 (IRF3) are tightly controlled via multiple post-translational modifications. Here, we identified a human ovarian tumor domain-containing deubiquitinase OTUD6B as a positive regulator of IRF3 that facilitates type I IFN innate antiviral immune signaling. Mechanically, we found that OTUD6B interacts with IRF3 and directly hydrolyzes both the lysine 11 (K11)- and the lysine 33 (K33)-linked polyubiquitin chain, but only K33-linked polyubiquitin at Lys315 of IRF3 is responsible for IRF3 proteasome degradation. Notably, OTUD6B enhanced cellular antiviral responses in vivo, as evidenced by mice that overexpressed human OTUD6B were more resistant to RNA virus infection and had reduced viral load and morbidity. These findings revealed a previously unknown role for OTUD6B in the regulation of innate antiviral immunity and may provide a potential target for enhancing host antiviral defense.IMPORTANCE Interferon (IFN) regulatory factor (IRF3) is one of the key factors for type I IFN transcription. To sophisticatedly regulate type I IFN antiviral immune response, IRF3 activity is closely controlled by a variety of post-translational modifications. However, the regulatory mechanisms are still not fully elucidated. In the present study, we found that human deubiquitinase OTUD6B positively regulates IRF3-mediated antiviral immune response. OTUD6B can stabilize the IRF3 protein level via hydrolyzing (Lys33)-linked polyubiquitin at Lys315. More importantly, mice with OTUD6B overexpression exhibited more resistance to RNA virus infection. Thus, unlike the previous report that zebrafish OTUD6B negatively regulates the antiviral response by suppressing K63-linked ubiquitination of IRF3 and IRF7, we demonstrate that human OTUD6B actually enhances type I IFN response and has the potential for antiviral therapy.

Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders

Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination

The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity

The Deubiquitinase OTUD1 Inhibits Colonic Inflammation by Suppressing RIPK1-mediated NF-κB Signaling

Deubiquitinase OTUD6A Regulates Innate Immune Response Via Targeting UBC13

Deubiquitinating enzyme OTUB1 in immunity and cancer: Good player or bad actor?

Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization

Human OTUD6B Positively Regulates Type I IFN Antiviral Innate Immune Responses by Deubiquitinating and Stabilizing IRF3.

OTUD1 Regulates Antifungal Innate Immunity Through Deubiquitination of CARD9.

OTUD1 deubiquitinase regulates NF-κB- and KEAP1-mediated inflammatory responses and reactive oxygen species-associated cell death pathways

Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1

Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3

OTUD5 promotes the inflammatory immune response by enhancing MyD88 oligomerization and Myddosome formation

Human OTULIN mutations can cause distinct inflammatory disease phenotypes depending on the protein domain that is mutated

OTUD7B deubiquitinates SQSTM1/p62 and promotes IRF3 degradation to regulate antiviral immunity

Pleiotropic Roles of a KEAP1-Associated Deubiquitinase, OTUD1

Acetylation-Dependent Deubiquitinase OTUD3 Controls MAVS Activation in Innate Antiviral Immunity

The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming.

OTUD1 Negatively Regulates Type I IFN Induction by Disrupting Noncanonical Ubiquitination of IRF3

The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity

The Deubiquitinase OTUD1 Deubiquitinates TIPE2 and Plays a Protective Role in Sepsis-Induced Lung Injury by Targeting TAK1-mediated MAPK and NF-κB Signaling